Tonix Pharmaceuticals (NASDAQ: TNXP)
Tonix Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Tonix Pharmaceuticals Company Info
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
News & Analysis
Why Tonix Pharmaceuticals Continued to Plummet Today
A spot of potentially good news can't stop the investor exodus from the biotech stock.
Why Tonix Pharmaceuticals Stock Is Crashing Again Today
The sell-off that began on Monday continues.
Why Tonix Pharmaceuticals Stock Dived by Over 31% Today
You'd plummet to the ground too if you declared a major reverse stock split.
Why Tonix Pharmaceuticals Got Crushed Today
Now is not a great time for pre-revenue biotechs to be reporting earnings.
Why Tonix Pharmaceuticals Is Down 19% Today
Buyers are unwinding their trades in a big way, following through on the profit-taking they initiated yesterday.
Why Tonix Pharmaceuticals Rocketed 33% Higher Today
The company wins orphan drug designation for one of its pipeline programs.
Why Tonix Pharmaceuticals Holdings Was a Winner on Wednesday
You'd pop the champagne, too, if you were included on a major industry stock index.
Why Tonix Pharmaceuticals Is Up by 6% Today
The company's path to regulatory approval for a key pipeline drug just got a bit shorter.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.